MedPath

Evaluating Technology Enabled Services in Perinatal Depression

Not Applicable
Completed
Conditions
Depression
Interventions
Behavioral: IntelliCare
Other: COMPASS-Care
Registration Number
NCT05525689
Lead Sponsor
Northwestern University
Brief Summary

Investigators are evaluating a Technology Enabled Service (TES) to support the treatment of depression in the context of a collaborative care service in obstetrics clinics.

Detailed Description

Investigators are evaluating a Technology Enabled Service (TES) to support the treatment of depression in the context of a collaborative care service in obstetrics clinics. The TES consists of digital technologies that connect patients to care managers remotely, providing tools for monitoring patient symptoms, communication, and delivery of a digital intervention. The intervention consists of a patient-facing app for assessment and self-management of depression.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
75
Inclusion Criteria
  • English speaking
  • 18 years or older
  • Referred to Northwestern Medicine COMPASS program for mental health care
  • Currently pregnant or within 3 months of delivery
  • Moderate to severe perinatal depression (defined as a PHQ-9 screen greater than or equal to 10)
  • Owns a smartphone, has used smartphone in last 7 days
Exclusion Criteria
  • Experienced a pregnancy loss (miscarriage, termination, or stillbirth of the index pregnancy)
  • Severe suicidality (as defined by the presence of a plan and intent to act on that plan)
  • Not meeting the inclusion criteria described above

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Technology Enabled ServiceIntelliCareAccess to the Intellicare suite of digital mental health self-management tools and coaching
eTreatment as UsualCOMPASS-CareCurrent care plus access to a website that will provide content specific to perinatal depression
Primary Outcome Measures
NameTimeMethod
DepressionContinuous - Up to 12 weeks

Assessed by Patient Health Questionnaire-9

Secondary Outcome Measures
NameTimeMethod
AnxietyContinuous - Up to 12 weeks

Assessed by General Anxiety Disorder - 7

Satisfaction with careWeek 6, Week 12

Assessed by Satisfaction Index - Mental Health. Items measured on a 6-point scale (72 points for entire scale) where higher scores reflect higher satisfaction.

Trial Locations

Locations (1)

Prentice Women's Hospital

🇺🇸

Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath